LANCET ONCOL 润色咨询

LANCET ONCOLOGY

出版年份:2000 年文章数:167 投稿命中率:35.0%

出版周期:Monthly 自引率:1.7% 审稿周期:平均1.4月

前往期刊查询

投稿信息

投稿信息
审稿速度
平均1.4月 (网友贡献,非官方数据)
投稿命中率
35.0% (网友贡献,非官方数据)
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2019年中国人文章占该期刊总数量10.78% (2018年为3.73%)
自引率
1.7 %
年文章数
167
期刊官网
点击查看 (点击次数:15349)
点击查看 (点击次数:5524次)
作者需知
点击查看 (点击次数:2018次)
期刊简介
稿件收录要求
PUBLISHED BY THE LANCET. ISSN: 1470-2045.

THE LANCET ONCOLOGY IS A MONTHLY, REVIEW JOURNAL, WITH ARTICLES, VIEWPOINTS, NEWS AND REVIEWS IN ONCOLOGY.

HISTORY

THE LANCET ONCOLOGY WAS LAUNCHED IN SEPTEMBER, 2000, AS A LIVELY AND INFORMATIVE MONTHLY JOURNAL COVERING INTERNATIONAL ISSUES RELEVANT TO CLINICAL CANCER SPECIALISTS WORLDWIDE. IN MAY, 2005, THE JOURNAL EXPANDED TO INCLUDE ORIGINAL RESEARCH AND BEGAN PUBLISHING ARTICLES ONLINE FIRST PRIOR TO PRINT PUBLICATION. THE JOURNAL QUICKLY ESTABLISHED ITSELF AS ONE OF THE PREMIER PUBLICATIONS WORLDWIDE FOR ORIGINAL RESEARCH, ESPECIALLY REPORTS FROM CLINICAL TRIALS, AND IN THE AREAS OF ADVOCACY AND GLOBAL HEALTH. UNIQUELY, ALL ORIGINAL RESEARCH IS PEER-REVIEWED VIA A FAST-TRACK SERVICE, AND SUCCESSFUL PAPERS ARE PUBLISHED WITHIN 8 WEEKS OF SUBMISSION. IN 2008, THE JOURNAL EXPANDED ITS ONLINE PRESENCE TO INCLUDE REGULAR PODCASTS.

THE LANCET ONCOLOGY HAS ALSO DEVELOPED A REPUTATION FOR HOSTING EVENTS FOR ONCOLOGISTS, CANCER RESEARCHERS, AND POLICYMAKERS. IN 2007, THE LANCET ONCOLOGY CONVENED ITS FIRST CONFERENCE IN SINGAPORE ENTITLED ASIA AND CANCER MANAGEMENTIN THE 21ST CENTURY. ADDITIONALLY IN 2007, THE JOURNAL HOSTED A PLENARY LECTURE AT THE ONCOLOGY CONGRESS IN SAN FRANCISCO, CA, USA, ON THE TOPIC OF DEVELOPMENTAL BIOLOGY, SELF RENEWAL, AND CANCER. IN SUBSEQUENT YEARS, THE JOURNAL HOSTED A SECOND PLENARY LECTURE AT THE 2008 ONCOLOGY CONGRESS, AND THE INAUGURAL ASIAN ONCOLOGY SUMMIT IN 2009. IN 2010, THE LANCET ONCOLOGY''''''''S INVOLVEMENT IN CONFERENCES EXPANDED WITH FURTHER EVENTS, INCLUDING A SECOND ASIAN ONCOLOGY SUMMIT IN BALI, INDONESIA, AND A CONFERENCE ON HPV AND CANCER IN AMSTERDAM, THE NETHERLANDS. SINCE 2011, THE JOURNAL HAS CONTINUED TO HOST THE SUCCESSFUL ASIAN ONCOLOGY SUMMITS AND IN 2015, THE LANCET ONCOLOGY WILL HOST THE 7TH ASIAN ONCOLOGY SUMMIT TO TAKE PLACE APRIL 10-12, 2015 IN SHANGHAI, CHINA. FURTHER EVENTS ARE PLANNED FOR 2016 AND BEYOND. THE JOURNAL IS ALSO INVOLVED IN CANCER HEALTH-CARE ADVOCACY BY PARTNERING WITH SPECIFIC ORGANISATIONS AND SOCIETIES.

REPUTATION AND IMPACT

THE LANCET ONCOLOGY HAS AN IMPACT FACTOR OF 24·725. THE JOURNAL RANKS THIRD OUT OF 202 ONCOLOGY JOURNALS WORLDWIDE, IS THE LEADING CLINICAL ONCOLOGY RESEARCH JOURNAL, AND IS IN THE TOP 0·5% OF ALL SCIENTIFIC JOURNALS, OF ANY DISCIPLINE, GLOBALLY (2013 JOURNAL CITATION REPORTS®, THOMSON REUTERS 2014). ARTICLES PUBLISHED IN THE LANCET ONCOLOGY REGULARLY RECEIVE COVERAGE IN THE MAINSTREAM PRINT, ONLINE, AND BROADCAST MEDIA.

COVERAGE

THE AIM OF THE LANCET ONCOLOGY IS TO PUBLISH INTERESTING, INFORMATIVE, AND PRACTICE-CHANGING ARTICLES ON ANY TOPIC CONNECTED WITH CLINICAL ONCOLOGY. TOPICS INCLUDE, BUT ARE NOT LIMITED TO:

  • BREAST CANCER
  • ENDOCRINE SYSTEM CANCER
  • GASTROINTESTINAL CANCER
  • GENITOURINARY CANCER
  • GYNAECOLOGICAL CANCER
  • HAEMATOLOGICAL CANCER
  • HEAD AND NECK CANCER
  • NEUROONCOLOGY
  • PAEDIATRIC ONCOLOGY
  • THORACIC ONCOLOGY
  • SARCOMA
  • SKIN CANCER
  • EPIDEMIOLOGY, CANCER PREVENTION, AND CANCER CONTROL
  • SUPPORTIVE CARE
  • IMAGING
  • HEALTH-CARE SYSTEMS
打开APP